Acasă › Supraponderalitate › Arizona

Studii clinice pentru Supraponderalitate în Arizona

29 studii pentru Supraponderalitate caută participanți în Arizona.

Orașe în Arizona

Text oficial al studiului (în engleză)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Headlands Research - Scottsdale /ID# 282571, Scottsdale

În curs de recrutareFaza 2

Vârste de la 18 la 75 · Toate sexele · Actualizat 2 oct. 2026 · NCT07752979

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

AMR Clinical, Tempe

În curs de recrutareFaza 2

Vârste de la 18 la 75 · Toate sexele · Actualizat 28 sept. 2026 · NCT07837973

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Care Access - 801 South Power Road, Mesa, Mesa
Absolute Clinical Research, Phoenix
Synexus Clinical Research US, Inc./Orange Grove Family Practice, Tucson

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07794579

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

University of Arizona, Tucson

În curs de recrutareFaza 3

Vârste de la 6 la 17 · Toate sexele · Actualizat 24 sept. 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Tucson Clinical Research Institute, Tucson

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

RIO Clinical Trials - Phoenix, Phoenix
Headlands Research - Scottsdale, Scottsdale
Novak Clinical Research - Tucson - North La Cholla Boulevard, Tucson

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Mesa
Research Site, Phoenix
Research Site, Tucson

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Synexus Clinical Research US, Inc., Phoenix
Medical Advancement Centers of Arizona, Phoenix

În curs de recrutareFaza 3

Vârste de la 45 la 99 · Toate sexele · Actualizat 22 sept. 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Headlands Research - Scottsdale, Scottsdale

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Care Access - 801 South Power Road, Mesa, Mesa
Elite Pain and Spine Institute - South Crimson Road, Mesa
Elite Clinical Studies, LLC, Phoenix
și încă 1

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler
Headlands Research - Scottsdale, Scottsdale
The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson

În curs de recrutareFaza 2

Vârste de la 18 la 75 · Toate sexele · Actualizat 22 sept. 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Phoenix
AURORA-1 Clinical Site, Tucson

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 16 sept. 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Peoria
AURORA-2 Clinical Site, Phoenix
AURORA-2 Clinical Site, Tucson

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 16 sept. 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Arizona Clinical Trials, Tucson

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 14 sept. 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Helios Clinical Research - Phoenix, Phoenix

În curs de recrutareFaza 2

Vârste de la 18 la 75 · Toate sexele · Actualizat 14 sept. 2026 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Arizona Clinical Trials, Tucson

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 14 sept. 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Chandler
ACCOMPLISH-2 Research Site, Phoenix
ACCOMPLISH-2 Research Site, Sun City West
și încă 1

În curs de recrutareFaza 3Voluntari sănătoși bineveniți

Vârste de la 18 la 79 · Toate sexele · Actualizat 11 sept. 2026 · NCT07654374

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Dignity Health, Mercy Gilbert, Gilbert

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 9 sept. 2026 · NCT07571109

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler
Headlands Research - Scottsdale, Scottsdale
The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson

În curs de recrutareFaza 2

Vârste de la 18 la 75 · Toate sexele · Actualizat 8 sept. 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC, Gilbert
Synexus Clinical Research US, Inc., Phoenix
Pima Heart, Tucson

În curs de recrutareFaza 2

Vârste de la 18 la 75 · Toate sexele · Actualizat 8 sept. 2026 · NCT07215559

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Medical Dermatology Specialists, Phoenix

În curs de recrutareFaza 4

Vârste de 18 ani și peste · Toate sexele · Actualizat 4 sept. 2026 · NCT06857942

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Phoenix
Kailera Clinical Site, Sun City

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 3 sept. 2026 · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Kailera Clinical Site, Sun City

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 3 sept. 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Gilbert Center for Family Medicine, Gilbert

În curs de recrutareFaza 3

Vârste de la 18 la 99 · Toate sexele · Actualizat 3 sept. 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Arizona Clinical Trials, Chandler
Epic Medical Research - Sun City, Sun City

În curs de recrutareFaza 3

Vârste de la 18 la 99 · Toate sexele · Actualizat 27 aug. 2026 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Research Site, Mesa

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 aug. 2026 · NCT07784725

Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity

Exponent Phoenix, Phoenix

În curs de recrutareStudiu observațional

Vârste de 18 ani și peste · Toate sexele · Actualizat 20 aug. 2026 · NCT07776678

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ACCOMPLISH-1 Research Site, Phoenix
ACCOMPLISH-1 Research Site, Sun City West
ACCOMPLISH-1 Research Site, Tucson

În curs de recrutareFaza 3

Vârste de la 18 la 79 · Toate sexele · Actualizat 10 aug. 2026 · NCT07654361

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

The University of Arizona College of Medicine- Phoenix, Phoenix

În curs de recrutareFaza 3

Vârste de la 18 la 75 · Toate sexele · Actualizat 14 nov. 2025 · NCT06499857

Sursă: ClinicalTrials.gov, date preluate la 3 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.